Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer

by Sudo, M., Chin, T.M., Mori, S., Doan, N.B., Said, J.W., Akashi, M., Koeffler, H.P.
Published 2014

Inecalcitol, an analog of 1α,25(OH) 2D 3, induces growth arrest of androgen-dependent prostate cancer cells

by Okamoto, R., Delansorne, R., Wakimoto, N., Doan, N.B., Akagi, T., Shen, M., Ho, Q.H., Said, J.W., Koeffler, H.P.
Published 2016

Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma

by Lee, D.H., Thoennissen, N.H., Goff, C., Iwanski, G.B., Forscher, C., Doan, N.B., Said, J.W., Phillip Koeffler, H.
Published 2016

MiR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme

by Yin, D., Ogawa, S., Kawamata, N., Leiter, A., Ham, M., Li, D., Doan, N.B., Said, J.W., Black, K.L., Phillip Koeffler, H.
Published 2016

Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma

by Thoennissen, N.H., Thoennissen, G.B., Abbassi, S., Nabavi-Nouis, S., Sauer, T., Doan, N.B., Gery, S., Müller-Tidow, C., Said, J.W., Koeffler, H.P.
Published 2016

PIAS4 is an activator of hypoxia signalling via VHL suppression during growth of pancreatic cancer cells

by Chien, W., Lee, K.L., Ding, L.W., Wuensche, P., Kato, H., Doan, N.B., Poellinger, L., Said, J.W., Koeffler, H.P.
Published 2014

Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival

by Lee, D.H., Amanat, S., Goff, C., Weiss, L.M., Said, J.W., Doan, N.B., Sato-Otsubo, A., Ogawa, S., Forscher, C., Koeffler, H.P.
Published 2016

Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets

by Kanojia, D, Garg, M, Martinez, J, Anand, M.T, Luty, S.B, Doan, N.B, Said, J.W, Forscher, C, Tyner, J.W, Koeffler, H.P
Published 2020

Off-target effects of c-MET inhibitors on thyroid cancer cells

by Zhou, Y., Zhao, C., Gery, S., Braunstein, G.D., Okamoto, R., Alvarez, R., Miles, S.A., Doan, N.B., Said, J.W., Gu, J., Phillip Koeffler, H.
Published 2016

Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer

by Iwanski, G.B., Lee, D.H., En-Gal, S., Doan, N.B., Castor, B., Vogt, M., Toh, M., Bokemeyer, C., Said, J.W., Thoennissen, N.H., Koeffler, H.P.
Published 2015

Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme

by Yin, D., Chen, W., O'Kelly, J., Lu, D., Ham, M., Doan, N.B., Xie, D., Wang, C., Vadgama, J., Said, J.W., Black, K.L., Koeffler, H.P.
Published 2016

Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma

by Garg, M, Kanojia, D, Mayakonda, A, Said, J.W, Doan, N.B, Chien, W, Ganesan, T.S, Chuang, L.S.H, Venkatachalam, N, Baloglu, E, Shacham, S, Kauffman, M, Koeffler, H.P
Published 2020

The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer

by Aribi, A., Gery, S., Lee, D.H., Thoennissen, N.H., Thoennissen, G.B., Alvarez, R., Ho, Q., Lee, K., Doan, N.B., Chan, K.T., Toh, M., Said, J.W., Koeffler, H.P.
Published 2016

Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin

by Garg, M, Kanojia, D, Mayakonda, A, Ganesan, T.S, Sadhanandhan, B, Suresh, S, Sneha, S, Nagare, R.P, Said, J.W, Doan, N.B, Ding, L.-W, Baloglu, E, Shacham, S, Kauffman, M, Koeffler, H.P
Published 2020

Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR

by Garg, M., Kanojia, D., Okamoto, R., Jain, S., Jain, V., Chien, W., Sampath, A., Ding, L.-W., Xuan, M., Said, J.W., Doan, N.B., Liu, L.-Z., Yang, H., Gery, S., Braunstein, G.D., Koeffler, H.P.
Published 2014

Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF)

by Yin, D., Yang, W.G., Weissberg, J., Goff, C.B., Chen, W., Kuwayama, Y., Leiter, A., Xing, H., Meixel, A., Gaut, D., Kirkbir, F., Sawcer, D., Vernier, P.T., Said, J.W., Gundersen, M.A., Koeffler, H.P.
Published 2016

Identification of a novel SYK/c-MYC/MALAT1 signaling pathway and its potential therapeutic value in Ewing sarcoma

by Sun, H, Lin, D.-C, Cao, Q, Pang, B, Gae, D.D, Lee, V.K.M, Lim, H.J, Doan, N, Said, J.W, Gery, S, Chow, M, Mayakonda, A, Forscher, C, Tyner, J.W, Koeffler, H.P
Published 2020

Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy

by Ran, XB, Ding, LW, Sun, QY, Yang, H, Said, JW, Zhentang, L, Madan, V, Dakle, P, Xiao, JF, Loh, X, Li, Y, Xu, L, Xiang, XQ, Wang, LZ, Goh, BC, Lin, DC, Chng, WJ, Tan, SY, Jha, S, Koeffler, HP
Published 2023

Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1

by Lin, L., Huang, M., Shi, X., Mayakonda, A., Hu, K., Jiang, Y.-Y., Guo, X., Chen, L., Pang, B., Doan, N., Said, J.W., Xie, J., Gery, S., Cheng, X., Lin, Z., Li, J., Berman, B.P., Yin, D., Lin, D.-C., Koeffler, H.P.
Published 2022

Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers

by Lin, D.-C., Xu, L., Ding, L.-W., Sharma, A., Liu, L.-Z., Yang, H., Tan, P., Vadgama, J., Karlan, B.Y., Lester, J., Urban, N., Schummer, M., Doan, N., Said, J.W., Sun, H., Walsh, M., Thomas, C.J., Patel, P., Yin, D., Chan, D., Phillip Koeffler, H.
Published 2014